After Musk’s X, Yaccarino Shifts to Run GLP-1 Tech Upstart (2)

Linda Yaccarino, who recently left Elon Musk’s X social media site, is taking the helm at eMed, a telehealth company that offers access to weight-loss drugs.

The digital health upstart sold Covid tests with results it confirmed virtually during the pandemic, then pivoted to offering weight-loss drugs more recently. The company announced Yaccarino’s appointment as chief executive officer on Tuesday.

She left X in July after two years, following a contentious effort to reverse an exodus of advertisers who were alienated by the site’s direction under Musk. Now Yaccarino’s going from one challenging situation to the next, and ...